Related Experiment Video
Updated: Jun 19, 2026
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
09:58
Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
Published on: November 9, 2018
Brain [18F]FDG PET in Encephalitis and Postinfectious Neurocognitive Syndromes.
Eric Guedj1, Tatiana Horowitz1, Antoine Verger2
1Aix-Marseille University (AMU), Department of Nuclear Medicine, Timone Hospital, IMoTheP Team, Institut Fresnel, Marseille, France.
PET Clinics
|June 17, 2026
Summary
Brain [18F]FDG PET imaging helps diagnose inflammatory brain diseases like autoimmune encephalitis by revealing metabolic changes. While useful in specific conditions, its application varies, and TSPO PET offers research-level insights into neuroinflammation.
Area of Science:
- Neurology
- Nuclear Medicine
- Radiology
Background:
- Brain [18F]FDG PET detects metabolic abnormalities, sometimes preceding or clarifying structural MRI findings.
- Its clinical rationale is strongest in autoimmune encephalitis, enhancing diagnostic sensitivity and pattern recognition.
Purpose of the Study:
- To review the utility of [18F]FDG PET in various inflammatory brain diseases.
- To highlight its role in autoimmune encephalitis, viral encephalitis, and post-COVID conditions.
- To differentiate its application from research-focused TSPO PET.
Main Methods:
- Review of current literature on [18F]FDG PET in inflammatory brain diseases.
- Analysis of diagnostic and prognostic contributions in specific neurological conditions.
- Comparison with Translocator Protein (TSPO) PET imaging.
Main Results:
- [18F]FDG PET significantly increases diagnostic sensitivity in autoimmune encephalitis.
- Its use is selective in viral encephalitis and supportive in post-COVID conditions for stratification and diagnosis.
- Interpretation requires careful consideration of clinical context and methodology.
Conclusions:
- [18F]FDG PET is a valuable tool for specific inflammatory brain diseases, particularly autoimmune encephalitis.
- Its role in viral encephalitis and post-COVID syndromes is selective but potentially impactful.
- TSPO PET provides mechanistic insights but remains primarily in the research domain.
Related Concept Videos
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...